Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM6CH2Drugs primarily affecting the autonomic nervous system
Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
XM1CE8Anticholinergics predominantly used for obstructive airway diseases

XM8BL4 category

Revefenacin

Also indexed as

Revefenacin

Nearby in Anticholinergics predominantly used for obstructive airway diseases

XM54K2Ipratropium bromide
XM55K5Oxitropium bromide
XM42V2Glycopyrronium bromide
XM6LS6Stramonium
XM9HA8Tiotropium bromide
XM2PE9Aclidinium bromide
XM3MF8Umeclidinium bromide
XM4DL3Flutropium bromide

PreviousXM3MF8 — Umeclidinium bromide NextXM4DL3 — Flutropium bromide

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM26S4Hormones and their synthetic substitutes or antagonists, not elsewhere classified
XM9W63Agents affecting bones, joints or other connective tissue, not elsewhere classified
XM4TG8Agents primarily affecting water and nutrition-balance or metabolism
XM3973Agents primarily affecting the cardiovascular system
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
14 more
Adrenergic agonists
Adrenergic antagonists
Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
Parasympathomimetics [cholinergics]
Ganglionic blocking drugs
XM4YB7Tritiozine
XM2973Tropacine
XM4466Tropicamide
XM8F25Trospium chloride
XM1CE8Anticholinergics predominantly used for obstructive airway diseases
XM9FU4Propiverine
XM82U8Tolterodine
XM2Z66Solifenacin
XM7V08Trospium
87 more
XM54K2Ipratropium bromide
XM55K5Oxitropium bromide
XM42V2Glycopyrronium bromide
XM6LS6Stramonium
XM9HA8Tiotropium bromide
XM2PE9Aclidinium bromide
XM3MF8Umeclidinium bromide
XM8BL4Revefenacin
XM4DL3Flutropium bromide

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact